Key market opportunities in the prefilled syringe fill finish sector include the rise in demand for self-medication, ...

Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there ...

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Fill / Finish Services Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the ...

BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated multi‑temperature 3PL support. YORK, PA, UNITED STATES, March 5, 2026 /EINPresswire.

The "Prefilled Syringe Fill Finish Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel ...

- Driven by the growing pipeline of injectable drugs, and increasing preference for self-medication, the demand for fill/finish services is anticipated to present lucrative opportunities for contract ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prefilled Syringes in 2017 & Beyond" report to their offering. The administration of therapeutic drugs via injection is ...

Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for COP over glass to mitigate ...

The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance ...

WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...

A company set up to provide safe, cheap prefilled syringes to developing countries is turning its expertise loose on the U.S. with the help of HHS and its first investor and financial promoter.

On May 12, the Defense Department and the Health and Human Services Department issued a $138 million contract to ApiJect Systems America to coordinate the production of prefilled syringes in ...